Cancer Stem Cell Specific Aptamer's Ability to Detect Blood Circulating Cancer Stem Cells and Its Role as a Predictor of Prognosis in Pancreatic Cancer
CompletedOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
March 29, 2018
Primary Completion Date
March 29, 2021
Study Completion Date
March 29, 2021
Conditions
Pancreatic Neoplasm
Trial Locations (1)
Unknown
Yonsei University Health System, Severance Hospital, Seoul
All Listed Sponsors
lead
Yonsei University
OTHER
NCT05745415 - Cancer Stem Cell Specific Aptamer's Ability to Detect Blood Circulating Cancer Stem Cells and Its Role as a Predictor of Prognosis in Pancreatic Cancer | Biotech Hunter | Biotech Hunter